IGXT is in discussions with 33 Pharmaceutical Companies maybe some of them wants to takeover IGXT

because IGXT is a gift here with a Market Cap of ridiculous $50 Million , its much more attractive to takeover IGXT than to pay royalties at this Levels .

With respect to other BD activities, we're clearly focusing right now in the business development area on bringing in new deals. For example at the recent BIO Conference, we met with 50 different pharmaceutical companies to discuss partnering opportunities, and we're currently in discussions with eight companies that are interested in RIZAPORT licenses, 17 companies that are interested in our Tadalafil product, three companies are interested in our schizophrenia drug, and five companies have expressed interest in a deal on Forfivo outside of the US.